JP2006514683A - ヒトｚｖｅｎアンタゴニストの使用 - Google Patents

Info

Publication number

JP2006514683A

JP2006514683A JP2005501095A JP2005501095A JP2006514683A JP 2006514683 A JP2006514683 A JP 2006514683A JP 2005501095 A JP2005501095 A JP 2005501095A JP 2005501095 A JP2005501095 A JP 2005501095A JP 2006514683 A JP2006514683 A JP 2006514683A

Authority

JP

Japan

Prior art keywords

seq

zven1

amino acid

zven2

polypeptide

Prior art date

2002-10-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 239000005557 antagonist Substances 0.000 title claims abstract description 46
• 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 374
• 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 310
• 229920001184 polypeptide Polymers 0.000 claims abstract description 287
• 238000000034 method Methods 0.000 claims abstract description 210
• 230000004054 inflammatory process Effects 0.000 claims abstract description 45
• 206010061218 Inflammation Diseases 0.000 claims abstract description 41
• 210000000936 intestine Anatomy 0.000 claims abstract description 19
• 150000007523 nucleic acids Chemical group 0.000 claims description 146
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 120
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 104
• 239000012634 fragment Substances 0.000 claims description 95
• 125000000539 amino acid group Chemical group 0.000 claims description 79
• 239000000523 sample Substances 0.000 claims description 58
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 48
• 208000002551 irritable bowel syndrome Diseases 0.000 claims description 46
• 102000040430 polynucleotide Human genes 0.000 claims description 41
• 108091033319 polynucleotide Proteins 0.000 claims description 41
• 239000002157 polynucleotide Substances 0.000 claims description 41
• 239000012472 biological sample Substances 0.000 claims description 37
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 30
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 30
• 238000012216 screening Methods 0.000 claims description 29
• 208000024891 symptom Diseases 0.000 claims description 27
• 241000124008 Mammalia Species 0.000 claims description 25
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 22
• 206010012735 Diarrhoea Diseases 0.000 claims description 20
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 18
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 18
• 230000003302 anti-idiotype Effects 0.000 claims description 18
• 230000002829 reductive effect Effects 0.000 claims description 12
• 230000001684 chronic effect Effects 0.000 claims description 10
• 208000011231 Crohn disease Diseases 0.000 claims description 8
• 230000014564 chemokine production Effects 0.000 abstract description 4
• 108090000623 proteins and genes Proteins 0.000 description 275
• 210000004027 cell Anatomy 0.000 description 173
• 102000039446 nucleic acids Human genes 0.000 description 142
• 108020004707 nucleic acids Proteins 0.000 description 142
• 102000004169 proteins and genes Human genes 0.000 description 129
• 125000003729 nucleotide group Chemical group 0.000 description 125
• 239000002773 nucleotide Substances 0.000 description 124
• 235000018102 proteins Nutrition 0.000 description 124
• 102000053602 DNA Human genes 0.000 description 94
• 235000001014 amino acid Nutrition 0.000 description 94
• 108020004414 DNA Proteins 0.000 description 93
• 229940024606 amino acid Drugs 0.000 description 72
• 150000001413 amino acids Chemical class 0.000 description 67
• 230000014509 gene expression Effects 0.000 description 67
• 230000000694 effects Effects 0.000 description 59
• 210000001519 tissue Anatomy 0.000 description 46
• 229920002477 rna polymer Polymers 0.000 description 45
• 239000000556 agonist Substances 0.000 description 41
• 239000013604 expression vector Substances 0.000 description 41
• 239000013598 vector Substances 0.000 description 41
• 238000003752 polymerase chain reaction Methods 0.000 description 40
• 239000000243 solution Substances 0.000 description 40
• 108020004635 Complementary DNA Proteins 0.000 description 39
• 241001465754 Metazoa Species 0.000 description 39
• 230000000295 complement effect Effects 0.000 description 39
• 102000005962 receptors Human genes 0.000 description 37
• 108020003175 receptors Proteins 0.000 description 37
• 238000010804 cDNA synthesis Methods 0.000 description 36
• 239000002299 complementary DNA Substances 0.000 description 36
• 108020004999 messenger RNA Proteins 0.000 description 34
• 230000027455 binding Effects 0.000 description 33
• 238000009396 hybridization Methods 0.000 description 33
• 238000006467 substitution reaction Methods 0.000 description 32
• 102000037865 fusion proteins Human genes 0.000 description 31
• 108020001507 fusion proteins Proteins 0.000 description 31
• 238000013459 approach Methods 0.000 description 30
• 238000012360 testing method Methods 0.000 description 29
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 28
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
• 230000000890 antigenic effect Effects 0.000 description 27
• 230000030136 gastric emptying Effects 0.000 description 26
• 238000011282 treatment Methods 0.000 description 26
• 210000001072 colon Anatomy 0.000 description 24
• 201000010099 disease Diseases 0.000 description 24
• 239000000203 mixture Substances 0.000 description 24
• 241000700605 Viruses Species 0.000 description 23
• 230000002496 gastric effect Effects 0.000 description 23
• 241000699670 Mus sp. Species 0.000 description 22
• 150000001875 compounds Chemical class 0.000 description 22
• 238000004519 manufacturing process Methods 0.000 description 22
• 210000000440 neutrophil Anatomy 0.000 description 22
• 230000001105 regulatory effect Effects 0.000 description 22
• 102000019034 Chemokines Human genes 0.000 description 21
• 108010012236 Chemokines Proteins 0.000 description 21
• 241000700159 Rattus Species 0.000 description 21
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 21
• 230000004044 response Effects 0.000 description 21
• 241000894007 species Species 0.000 description 21
• 230000001225 therapeutic effect Effects 0.000 description 21
• 108020004705 Codon Proteins 0.000 description 20
• ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 20
• 108010076504 Protein Sorting Signals Proteins 0.000 description 20
• -1 inositol lipid Chemical class 0.000 description 20
• 238000013518 transcription Methods 0.000 description 20
• 230000035897 transcription Effects 0.000 description 20
• 238000010561 standard procedure Methods 0.000 description 19
• 239000003795 chemical substances by application Substances 0.000 description 18
• 238000010367 cloning Methods 0.000 description 18
• 230000000968 intestinal effect Effects 0.000 description 18
• 241000588724 Escherichia coli Species 0.000 description 17
• 238000004458 analytical method Methods 0.000 description 17
• 238000001514 detection method Methods 0.000 description 17
• 208000002193 Pain Diseases 0.000 description 16
• 241000283984 Rodentia Species 0.000 description 16
• 206010047700 Vomiting Diseases 0.000 description 16
• 230000001965 increasing effect Effects 0.000 description 16
• 235000012054 meals Nutrition 0.000 description 16
• 230000036407 pain Effects 0.000 description 16
• 230000003248 secreting effect Effects 0.000 description 16
• 239000007787 solid Substances 0.000 description 16
• 239000000427 antigen Substances 0.000 description 15
• 108091007433 antigens Proteins 0.000 description 15
• 102000036639 antigens Human genes 0.000 description 15
• 239000000872 buffer Substances 0.000 description 15
• 238000000746 purification Methods 0.000 description 15
• 241000701447 unidentified baculovirus Species 0.000 description 15
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 14
• 238000005516 engineering process Methods 0.000 description 14
• 239000013612 plasmid Substances 0.000 description 14
• 241000701161 unidentified adenovirus Species 0.000 description 14
• 230000008673 vomiting Effects 0.000 description 14
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 13
• 241000196324 Embryophyta Species 0.000 description 13
• 206010028980 Neoplasm Diseases 0.000 description 13
• 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 13
• 239000003814 drug Substances 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 230000008595 infiltration Effects 0.000 description 13
• 238000001764 infiltration Methods 0.000 description 13
• 108090000790 Enzymes Proteins 0.000 description 12
• 108091034117 Oligonucleotide Proteins 0.000 description 12
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
• 208000025865 Ulcer Diseases 0.000 description 12
• 238000003556 assay Methods 0.000 description 12
• 239000011324 bead Substances 0.000 description 12
• 230000037430 deletion Effects 0.000 description 12
• 238000012217 deletion Methods 0.000 description 12
• 229920003045 dextran sodium sulfate Polymers 0.000 description 12
• 229940088598 enzyme Drugs 0.000 description 12
• 208000015181 infectious disease Diseases 0.000 description 12
• 210000002784 stomach Anatomy 0.000 description 12
• 239000000126 substance Substances 0.000 description 12
• 102000004190 Enzymes Human genes 0.000 description 11
• 241001452677 Ogataea methanolica Species 0.000 description 11
• 230000001580 bacterial effect Effects 0.000 description 11
• 201000011510 cancer Diseases 0.000 description 11
• 210000001035 gastrointestinal tract Anatomy 0.000 description 11
• 210000004962 mammalian cell Anatomy 0.000 description 11
• 239000013615 primer Substances 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 238000012546 transfer Methods 0.000 description 11
• 241000238631 Hexapoda Species 0.000 description 10
• 241001529936 Murinae Species 0.000 description 10
• 210000001744 T-lymphocyte Anatomy 0.000 description 10
• 150000001408 amides Chemical class 0.000 description 10
• 230000008859 change Effects 0.000 description 10
• 229940079593 drug Drugs 0.000 description 10
• 230000006870 function Effects 0.000 description 10
• 230000001976 improved effect Effects 0.000 description 10
• 231100000397 ulcer Toxicity 0.000 description 10
• 230000015572 biosynthetic process Effects 0.000 description 9
• 206010009887 colitis Diseases 0.000 description 9
• 230000029087 digestion Effects 0.000 description 9
• 239000003937 drug carrier Substances 0.000 description 9
• 229940127121 immunoconjugate Drugs 0.000 description 9
• 238000000338 in vitro Methods 0.000 description 9
• 239000007788 liquid Substances 0.000 description 9
• 239000003550 marker Substances 0.000 description 9
• 230000035772 mutation Effects 0.000 description 9
• 241000282472 Canis lupus familiaris Species 0.000 description 8
• 108090000994 Catalytic RNA Proteins 0.000 description 8
• 102000053642 Catalytic RNA Human genes 0.000 description 8
• 108060003951 Immunoglobulin Proteins 0.000 description 8
• 108010050904 Interferons Proteins 0.000 description 8
• 102000014150 Interferons Human genes 0.000 description 8
• 239000002253 acid Substances 0.000 description 8
• 230000004913 activation Effects 0.000 description 8
• 229960002685 biotin Drugs 0.000 description 8
• 239000011616 biotin Substances 0.000 description 8
• 230000001413 cellular effect Effects 0.000 description 8
• 238000006731 degradation reaction Methods 0.000 description 8
• 238000004520 electroporation Methods 0.000 description 8
• 230000005176 gastrointestinal motility Effects 0.000 description 8
• 102000018358 immunoglobulin Human genes 0.000 description 8
• 230000001939 inductive effect Effects 0.000 description 8
• 239000007924 injection Substances 0.000 description 8
• 238000002347 injection Methods 0.000 description 8
• 229940079322 interferon Drugs 0.000 description 8
• 238000002955 isolation Methods 0.000 description 8
• 239000003446 ligand Substances 0.000 description 8
• 230000004899 motility Effects 0.000 description 8
• 238000002703 mutagenesis Methods 0.000 description 8
• 231100000350 mutagenesis Toxicity 0.000 description 8
• 238000011160 research Methods 0.000 description 8
• 108091092562 ribozyme Proteins 0.000 description 8
• 238000003786 synthesis reaction Methods 0.000 description 8
• 230000014616 translation Effects 0.000 description 8
• 239000013603 viral vector Substances 0.000 description 8
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
• 102000016950 Chemokine CXCL1 Human genes 0.000 description 7
• 206010010774 Constipation Diseases 0.000 description 7
• 241000282412 Homo Species 0.000 description 7
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 7
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 7
• 235000020958 biotin Nutrition 0.000 description 7
• 230000015556 catabolic process Effects 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 230000004927 fusion Effects 0.000 description 7
• 230000002068 genetic effect Effects 0.000 description 7
• 230000000984 immunochemical effect Effects 0.000 description 7
• 230000004968 inflammatory condition Effects 0.000 description 7
• 208000003243 intestinal obstruction Diseases 0.000 description 7
• 230000003834 intracellular effect Effects 0.000 description 7
• 239000011159 matrix material Substances 0.000 description 7
• 239000008188 pellet Substances 0.000 description 7
• 239000008194 pharmaceutical composition Substances 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 238000001356 surgical procedure Methods 0.000 description 7
• 238000013519 translation Methods 0.000 description 7
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
• 108010014419 Chemokine CXCL1 Proteins 0.000 description 6
• KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 6
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 206010028813 Nausea Diseases 0.000 description 6
• BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 6
• 206010040047 Sepsis Diseases 0.000 description 6
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
• 238000001042 affinity chromatography Methods 0.000 description 6
• KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 6
• 230000033115 angiogenesis Effects 0.000 description 6
• 238000010171 animal model Methods 0.000 description 6
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
• 230000008602 contraction Effects 0.000 description 6
• 238000003745 diagnosis Methods 0.000 description 6
• 235000013305 food Nutrition 0.000 description 6
• 108010055341 glutamyl-glutamic acid Proteins 0.000 description 6
• 210000002429 large intestine Anatomy 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 210000004379 membrane Anatomy 0.000 description 6
• TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 6
• 230000008693 nausea Effects 0.000 description 6
• 230000037361 pathway Effects 0.000 description 6
• 238000002823 phage display Methods 0.000 description 6
• 229960003531 phenolsulfonphthalein Drugs 0.000 description 6
• 230000035945 sensitivity Effects 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• 238000005406 washing Methods 0.000 description 6
• 241000894006 Bacteria Species 0.000 description 5
• 102000004127 Cytokines Human genes 0.000 description 5
• 108090000695 Cytokines Proteins 0.000 description 5
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
• VNQABZCSYCTZMS-UHFFFAOYSA-N Orthoform Chemical compound COC(=O)C1=CC=C(O)C(N)=C1 VNQABZCSYCTZMS-UHFFFAOYSA-N 0.000 description 5
• 241000283973 Oryctolagus cuniculus Species 0.000 description 5
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 5
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 5
• 102000004167 Ribonuclease P Human genes 0.000 description 5
• 108090000621 Ribonuclease P Proteins 0.000 description 5
• 230000002159 abnormal effect Effects 0.000 description 5
• 230000003321 amplification Effects 0.000 description 5
• 230000002391 anti-complement effect Effects 0.000 description 5
• 230000000692 anti-sense effect Effects 0.000 description 5
• 108010008730 anticomplement Proteins 0.000 description 5
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 5
• 229960002170 azathioprine Drugs 0.000 description 5
• 230000008901 benefit Effects 0.000 description 5
• 239000003153 chemical reaction reagent Substances 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 238000007796 conventional method Methods 0.000 description 5
• 230000002950 deficient Effects 0.000 description 5
• 206010012601 diabetes mellitus Diseases 0.000 description 5
• 239000012530 fluid Substances 0.000 description 5
• 238000001415 gene therapy Methods 0.000 description 5
• 210000004408 hybridoma Anatomy 0.000 description 5
• 210000003405 ileum Anatomy 0.000 description 5
• 230000002163 immunogen Effects 0.000 description 5
• 238000011534 incubation Methods 0.000 description 5
• 230000002401 inhibitory effect Effects 0.000 description 5
• 230000000977 initiatory effect Effects 0.000 description 5
• 238000003780 insertion Methods 0.000 description 5
• 230000037431 insertion Effects 0.000 description 5
• 239000007928 intraperitoneal injection Substances 0.000 description 5
• 210000003292 kidney cell Anatomy 0.000 description 5
• 230000003902 lesion Effects 0.000 description 5
• 239000002502 liposome Substances 0.000 description 5
• 239000006166 lysate Substances 0.000 description 5
• 238000005259 measurement Methods 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 239000012528 membrane Substances 0.000 description 5
• 238000003199 nucleic acid amplification method Methods 0.000 description 5
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
• 230000002285 radioactive effect Effects 0.000 description 5
• 229920005989 resin Polymers 0.000 description 5
• 239000011347 resin Substances 0.000 description 5
• 108091008146 restriction endonucleases Proteins 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 238000012163 sequencing technique Methods 0.000 description 5
• 238000002741 site-directed mutagenesis Methods 0.000 description 5
• 239000007790 solid phase Substances 0.000 description 5
• 235000000346 sugar Nutrition 0.000 description 5
• 230000002103 transcriptional effect Effects 0.000 description 5
• 238000001890 transfection Methods 0.000 description 5
• 239000003981 vehicle Substances 0.000 description 5
• 230000003612 virological effect Effects 0.000 description 5
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
• 229920000936 Agarose Polymers 0.000 description 4
• 108020005544 Antisense RNA Proteins 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• 102000014914 Carrier Proteins Human genes 0.000 description 4
• 108091026890 Coding region Proteins 0.000 description 4
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 4
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 4
• 108020004711 Nucleic Acid Probes Proteins 0.000 description 4
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
• 239000004793 Polystyrene Substances 0.000 description 4
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
• 241000700584 Simplexvirus Species 0.000 description 4
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
• 230000001154 acute effect Effects 0.000 description 4
• 239000000074 antisense oligonucleotide Substances 0.000 description 4
• 238000012230 antisense oligonucleotides Methods 0.000 description 4
• 230000009286 beneficial effect Effects 0.000 description 4
• 108091008324 binding proteins Proteins 0.000 description 4
• 238000001574 biopsy Methods 0.000 description 4
• 210000004556 brain Anatomy 0.000 description 4
• 229910052791 calcium Inorganic materials 0.000 description 4
• 239000011575 calcium Substances 0.000 description 4
• 239000003184 complementary RNA Substances 0.000 description 4
• 230000000875 corresponding effect Effects 0.000 description 4
• 239000003246 corticosteroid Substances 0.000 description 4
• 230000008878 coupling Effects 0.000 description 4
• 238000010168 coupling process Methods 0.000 description 4
• 238000005859 coupling reaction Methods 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 230000003111 delayed effect Effects 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 238000012377 drug delivery Methods 0.000 description 4
• 239000002158 endotoxin Substances 0.000 description 4
• 210000003527 eukaryotic cell Anatomy 0.000 description 4
• 230000037406 food intake Effects 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• 239000000499 gel Substances 0.000 description 4
• 239000011521 glass Substances 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 238000002744 homologous recombination Methods 0.000 description 4
• 230000006801 homologous recombination Effects 0.000 description 4
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 238000003018 immunoassay Methods 0.000 description 4
• 230000005847 immunogenicity Effects 0.000 description 4
• 239000003018 immunosuppressive agent Substances 0.000 description 4
• 238000007901 in situ hybridization Methods 0.000 description 4
• 238000000099 in vitro assay Methods 0.000 description 4
• 230000004941 influx Effects 0.000 description 4
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 238000002372 labelling Methods 0.000 description 4
• 229920006008 lipopolysaccharide Polymers 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 229920002521 macromolecule Polymers 0.000 description 4
• 239000004005 microsphere Substances 0.000 description 4
• 230000002297 mitogenic effect Effects 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 210000004877 mucosa Anatomy 0.000 description 4
• 239000002853 nucleic acid probe Substances 0.000 description 4
• 238000010647 peptide synthesis reaction Methods 0.000 description 4
• 239000013600 plasmid vector Substances 0.000 description 4
• 229920002223 polystyrene Polymers 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 238000012545 processing Methods 0.000 description 4
• 231100000241 scar Toxicity 0.000 description 4
• 230000028327 secretion Effects 0.000 description 4
• 230000002269 spontaneous effect Effects 0.000 description 4
• 230000035882 stress Effects 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 4
• 241001515965 unidentified phage Species 0.000 description 4
• 238000011144 upstream manufacturing Methods 0.000 description 4
• 208000016261 weight loss Diseases 0.000 description 4
• 230000004580 weight loss Effects 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• NHJVRSWLHSJWIN-UHFFFAOYSA-N 2,4,6-trinitrobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O NHJVRSWLHSJWIN-UHFFFAOYSA-N 0.000 description 3
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 3
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
• 206010000060 Abdominal distension Diseases 0.000 description 3
• 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 241000271566 Aves Species 0.000 description 3
• 108090001008 Avidin Proteins 0.000 description 3
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Chemical group C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 3
• 235000014469 Bacillus subtilis Nutrition 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
• 102100035882 Catalase Human genes 0.000 description 3
• 108010053835 Catalase Proteins 0.000 description 3
• 241000700199 Cavia porcellus Species 0.000 description 3
• 108010047041 Complementarity Determining Regions Proteins 0.000 description 3
• 239000003155 DNA primer Substances 0.000 description 3
• 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 3
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
• 101150029662 E1 gene Proteins 0.000 description 3
• 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 3
• 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 3
• 208000018522 Gastrointestinal disease Diseases 0.000 description 3
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
• 108010070675 Glutathione transferase Proteins 0.000 description 3
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
• 102100029100 Hematopoietic prostaglandin D synthase Human genes 0.000 description 3
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 3
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 241000699660 Mus musculus Species 0.000 description 3
• 101000889134 Mus musculus C-X-C motif chemokine 2 Proteins 0.000 description 3
• 102000057297 Pepsin A Human genes 0.000 description 3
• 108090000284 Pepsin A Proteins 0.000 description 3
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 3
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
• 206010037660 Pyrexia Diseases 0.000 description 3
• 108091034057 RNA (poly(A)) Proteins 0.000 description 3
• 206010070834 Sensitisation Diseases 0.000 description 3
• 229920002684 Sepharose Polymers 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108020004682 Single-Stranded DNA Proteins 0.000 description 3
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 3
• 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 3
• 108700005078 Synthetic Genes Proteins 0.000 description 3
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 3
• 241000906446 Theraps Species 0.000 description 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
• 210000000683 abdominal cavity Anatomy 0.000 description 3
• 150000007513 acids Chemical class 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 239000007801 affinity label Substances 0.000 description 3
• 230000002491 angiogenic effect Effects 0.000 description 3
• 210000002376 aorta thoracic Anatomy 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 230000006399 behavior Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• 239000007853 buffer solution Substances 0.000 description 3
• 238000004422 calculation algorithm Methods 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 150000001720 carbohydrates Chemical class 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 230000003197 catalytic effect Effects 0.000 description 3
• 239000003610 charcoal Substances 0.000 description 3
• 230000035605 chemotaxis Effects 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• 210000000349 chromosome Anatomy 0.000 description 3
• 208000037976 chronic inflammation Diseases 0.000 description 3
• 230000006020 chronic inflammation Effects 0.000 description 3
• 239000013599 cloning vector Substances 0.000 description 3
• 230000001268 conjugating effect Effects 0.000 description 3
• 238000012258 culturing Methods 0.000 description 3
• 230000000593 degrading effect Effects 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 210000004921 distal colon Anatomy 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
• 239000007850 fluorescent dye Substances 0.000 description 3
• 238000003304 gavage Methods 0.000 description 3
• 238000007429 general method Methods 0.000 description 3
• 238000010353 genetic engineering Methods 0.000 description 3
• 239000008103 glucose Substances 0.000 description 3
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
• 208000027909 hemorrhagic diarrhea Diseases 0.000 description 3
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000003053 immunization Effects 0.000 description 3
• 230000016784 immunoglobulin production Effects 0.000 description 3
• 229960003444 immunosuppressant agent Drugs 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 239000012678 infectious agent Substances 0.000 description 3
• 238000007912 intraperitoneal administration Methods 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 230000033001 locomotion Effects 0.000 description 3
• 230000007774 longterm Effects 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 230000005291 magnetic effect Effects 0.000 description 3
• 230000007246 mechanism Effects 0.000 description 3
• 229910021645 metal ion Inorganic materials 0.000 description 3
• 229960000485 methotrexate Drugs 0.000 description 3
• 229920000609 methyl cellulose Polymers 0.000 description 3
• 239000001923 methylcellulose Substances 0.000 description 3
• 239000000178 monomer Substances 0.000 description 3
• 230000036961 partial effect Effects 0.000 description 3
• 230000007170 pathology Effects 0.000 description 3
• 229940111202 pepsin Drugs 0.000 description 3
• 210000001322 periplasm Anatomy 0.000 description 3
• 210000004303 peritoneum Anatomy 0.000 description 3
• 239000002987 primer (paints) Substances 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 238000001742 protein purification Methods 0.000 description 3
• 210000000664 rectum Anatomy 0.000 description 3
• 238000012340 reverse transcriptase PCR Methods 0.000 description 3
• 230000008313 sensitization Effects 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 210000000813 small intestine Anatomy 0.000 description 3
• 239000011734 sodium Substances 0.000 description 3
• 230000009870 specific binding Effects 0.000 description 3
• 230000002194 synthesizing effect Effects 0.000 description 3
• 230000008719 thickening Effects 0.000 description 3
• 125000003396 thiol group Chemical group [H]S* 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 238000011830 transgenic mouse model Methods 0.000 description 3
• 241001529453 unidentified herpesvirus Species 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• 208000009935 visceral pain Diseases 0.000 description 3
• PDRJLZDUOULRHE-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-2-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=N1 PDRJLZDUOULRHE-ZETCQYMHSA-N 0.000 description 2
• FQFVANSXYKWQOT-ZETCQYMHSA-N (2s)-2-azaniumyl-3-pyridin-4-ylpropanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=NC=C1 FQFVANSXYKWQOT-ZETCQYMHSA-N 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
• VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
• CKTSBUTUHBMZGZ-ULQXZJNLSA-N 4-amino-1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-tritiopyrimidin-2-one Chemical group O=C1N=C(N)C([3H])=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-ULQXZJNLSA-N 0.000 description 2
• WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
• XWHHYOYVRVGJJY-QMMMGPOBSA-N 4-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(F)C=C1 XWHHYOYVRVGJJY-QMMMGPOBSA-N 0.000 description 2
• 208000004998 Abdominal Pain Diseases 0.000 description 2
• 244000215068 Acacia senegal Species 0.000 description 2
• 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• 244000105975 Antidesma platyphyllum Species 0.000 description 2
• 101100437118 Arabidopsis thaliana AUG1 gene Proteins 0.000 description 2
• 101100437119 Arabidopsis thaliana AUG2 gene Proteins 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 241000972773 Aulopiformes Species 0.000 description 2
• 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 2
• 108050001427 Avidin/streptavidin Proteins 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 244000063299 Bacillus subtilis Species 0.000 description 2
• 108010077805 Bacterial Proteins Proteins 0.000 description 2
• 208000002177 Cataract Diseases 0.000 description 2
• 241000700198 Cavia Species 0.000 description 2
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
• 208000032544 Cicatrix Diseases 0.000 description 2
• 108020004638 Circular DNA Proteins 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 206010010904 Convulsion Diseases 0.000 description 2
• 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 2
• 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 2
• IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
• 208000032131 Diabetic Neuropathies Diseases 0.000 description 2
• SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
• 206010059866 Drug resistance Diseases 0.000 description 2
• 102000006402 Endocrine-Gland-Derived Vascular Endothelial Growth Factor Human genes 0.000 description 2
• 108010044063 Endocrine-Gland-Derived Vascular Endothelial Growth Factor Proteins 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 241000283086 Equidae Species 0.000 description 2
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
• 241000701959 Escherichia virus Lambda Species 0.000 description 2
• 108091029865 Exogenous DNA Proteins 0.000 description 2
• 108060002716 Exonuclease Proteins 0.000 description 2
• 108010067193 Formaldehyde transketolase Proteins 0.000 description 2
• 108090000698 Formate Dehydrogenases Proteins 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 108010024636 Glutathione Proteins 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 229920000084 Gum arabic Polymers 0.000 description 2
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 2
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 2
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
• 102000004877 Insulin Human genes 0.000 description 2
• 108090001061 Insulin Proteins 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 241000235058 Komagataella pastoris Species 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
• 108090000157 Metallothionein Proteins 0.000 description 2
• 208000019695 Migraine disease Diseases 0.000 description 2
• 238000005481 NMR spectroscopy Methods 0.000 description 2
• 229930193140 Neomycin Natural products 0.000 description 2
• 108091092724 Noncoding DNA Proteins 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• 108091060545 Nonsense suppressor Proteins 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 238000012408 PCR amplification Methods 0.000 description 2
• 208000007542 Paresis Diseases 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 108010067902 Peptide Library Proteins 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 241000288906 Primates Species 0.000 description 2
• 101710111770 Prokineticin receptor 1 Proteins 0.000 description 2
• 102100030364 Prokineticin receptor 1 Human genes 0.000 description 2
• 101710111765 Prokineticin receptor 2 Proteins 0.000 description 2
• 102100030363 Prokineticin receptor 2 Human genes 0.000 description 2
• 102100040125 Prokineticin-2 Human genes 0.000 description 2
• 101710103829 Prokineticin-2 Proteins 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 108010009460 RNA Polymerase II Proteins 0.000 description 2
• 102000009572 RNA Polymerase II Human genes 0.000 description 2
• 108020004511 Recombinant DNA Proteins 0.000 description 2
• 206010057190 Respiratory tract infections Diseases 0.000 description 2
• 108091027981 Response element Proteins 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
• 239000004098 Tetracycline Substances 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 108700005077 Viral Genes Proteins 0.000 description 2
• 230000003187 abdominal effect Effects 0.000 description 2
• 239000000205 acacia gum Substances 0.000 description 2
• 235000010489 acacia gum Nutrition 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 239000011543 agarose gel Substances 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 125000003282 alkyl amino group Chemical group 0.000 description 2
• 150000001412 amines Chemical class 0.000 description 2
• 238000003277 amino acid sequence analysis Methods 0.000 description 2
• 229940113720 aminosalicylate Drugs 0.000 description 2
• 229960000723 ampicillin Drugs 0.000 description 2
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
• 230000003474 anti-emetic effect Effects 0.000 description 2
• 229940121363 anti-inflammatory agent Drugs 0.000 description 2
• 239000002260 anti-inflammatory agent Substances 0.000 description 2
• 230000006472 autoimmune response Effects 0.000 description 2
• 238000000376 autoradiography Methods 0.000 description 2
• TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
• 230000003115 biocidal effect Effects 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000002051 biphasic effect Effects 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 210000000988 bone and bone Anatomy 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 229950004398 broxuridine Drugs 0.000 description 2
• 239000008366 buffered solution Substances 0.000 description 2
• 244000309464 bull Species 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 238000004364 calculation method Methods 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 125000000837 carbohydrate group Chemical group 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 210000002318 cardia Anatomy 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 238000007385 chemical modification Methods 0.000 description 2
• 239000012501 chromatography medium Substances 0.000 description 2
• 230000004087 circulation Effects 0.000 description 2
• PMMYEEVYMWASQN-IMJSIDKUSA-N cis-4-Hydroxy-L-proline Chemical compound O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 2
• DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
• 229960004316 cisplatin Drugs 0.000 description 2
• 238000003501 co-culture Methods 0.000 description 2
• 230000000112 colonic effect Effects 0.000 description 2
• 230000002860 competitive effect Effects 0.000 description 2
• 238000012790 confirmation Methods 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 239000000356 contaminant Substances 0.000 description 2
• 229960001334 corticosteroids Drugs 0.000 description 2
• 229940095074 cyclic amp Drugs 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000000368 destabilizing effect Effects 0.000 description 2
• 238000000502 dialysis Methods 0.000 description 2
• 235000005911 diet Nutrition 0.000 description 2
• 230000037213 diet Effects 0.000 description 2
• 208000010643 digestive system disease Diseases 0.000 description 2
• QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
• SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 230000005684 electric field Effects 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 230000002708 enhancing effect Effects 0.000 description 2
• ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
• 102000013165 exonuclease Human genes 0.000 description 2
• 238000000605 extraction Methods 0.000 description 2
• 235000012631 food intake Nutrition 0.000 description 2
• 238000005194 fractionation Methods 0.000 description 2
• 238000013467 fragmentation Methods 0.000 description 2
• 238000006062 fragmentation reaction Methods 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 230000007661 gastrointestinal function Effects 0.000 description 2
• 208000018685 gastrointestinal system disease Diseases 0.000 description 2
• 238000001502 gel electrophoresis Methods 0.000 description 2
• 102000054767 gene variant Human genes 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 2
• 235000009424 haa Nutrition 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• 210000000987 immune system Anatomy 0.000 description 2
• 230000036039 immunity Effects 0.000 description 2
• 238000002649 immunization Methods 0.000 description 2
• 239000007943 implant Substances 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 210000004969 inflammatory cell Anatomy 0.000 description 2
• 208000027866 inflammatory disease Diseases 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 230000028709 inflammatory response Effects 0.000 description 2
• 229960000598 infliximab Drugs 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 229940125396 insulin Drugs 0.000 description 2
• 238000001361 intraarterial administration Methods 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 238000010253 intravenous injection Methods 0.000 description 2
• 238000004255 ion exchange chromatography Methods 0.000 description 2
• 150000002500 ions Chemical class 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 101150066555 lacZ gene Proteins 0.000 description 2
• 108020001756 ligand binding domains Proteins 0.000 description 2
• 238000007834 ligase chain reaction Methods 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 238000001638 lipofection Methods 0.000 description 2
• 239000008263 liquid aerosol Substances 0.000 description 2
• KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
• 244000144972 livestock Species 0.000 description 2
• 238000004020 luminiscence type Methods 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 238000012423 maintenance Methods 0.000 description 2
• 239000000463 material Substances 0.000 description 2
• 238000002844 melting Methods 0.000 description 2
• 230000008018 melting Effects 0.000 description 2
• 230000015654 memory Effects 0.000 description 2
• GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 description 2
• 229960001428 mercaptopurine Drugs 0.000 description 2
• CWWARWOPSKGELM-SARDKLJWSA-N methyl (2s)-2-[[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-5-amino-2-[[(2s)-5-amino-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-1-[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-5 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)OC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 CWWARWOPSKGELM-SARDKLJWSA-N 0.000 description 2
• 206010027599 migraine Diseases 0.000 description 2
• 235000013336 milk Nutrition 0.000 description 2
• 210000004080 milk Anatomy 0.000 description 2
• 239000008267 milk Substances 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 210000004400 mucous membrane Anatomy 0.000 description 2
• 210000003097 mucus Anatomy 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 230000037125 natural defense Effects 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• 229960004927 neomycin Drugs 0.000 description 2
• 201000001119 neuropathy Diseases 0.000 description 2
• 230000007823 neuropathy Effects 0.000 description 2
• 239000002858 neurotransmitter agent Substances 0.000 description 2
• 230000037434 nonsense mutation Effects 0.000 description 2
• 230000009871 nonspecific binding Effects 0.000 description 2
• 210000004940 nucleus Anatomy 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 210000003463 organelle Anatomy 0.000 description 2
• 229910052760 oxygen Inorganic materials 0.000 description 2
• 229960005489 paracetamol Drugs 0.000 description 2
• 239000002245 particle Substances 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• 208000033808 peripheral neuropathy Diseases 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 239000008055 phosphate buffer solution Substances 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 230000035479 physiological effects, processes and functions Effects 0.000 description 2
• 229920002401 polyacrylamide Polymers 0.000 description 2
• 229920002704 polyhistidine Polymers 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• 210000001236 prokaryotic cell Anatomy 0.000 description 2
• 150000003212 purines Chemical class 0.000 description 2
• RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 2
• 210000004915 pus Anatomy 0.000 description 2
• 150000003230 pyrimidines Chemical class 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000010076 replication Effects 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 235000019515 salmon Nutrition 0.000 description 2
• FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
• 230000037387 scars Effects 0.000 description 2
• 208000018316 severe headache Diseases 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 239000000377 silicon dioxide Substances 0.000 description 2
• 238000001542 size-exclusion chromatography Methods 0.000 description 2
• 230000016160 smooth muscle contraction Effects 0.000 description 2
• 239000001509 sodium citrate Substances 0.000 description 2
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
• 238000010532 solid phase synthesis reaction Methods 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 230000004206 stomach function Effects 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 229910052717 sulfur Inorganic materials 0.000 description 2
• 239000011593 sulfur Substances 0.000 description 2
• 230000001629 suppression Effects 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 229960002180 tetracycline Drugs 0.000 description 2
• 229930101283 tetracycline Natural products 0.000 description 2
• 235000019364 tetracycline Nutrition 0.000 description 2
• 150000003522 tetracyclines Chemical class 0.000 description 2
• 229940124597 therapeutic agent Drugs 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• 230000019432 tissue death Effects 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 230000036269 ulceration Effects 0.000 description 2
• 230000024883 vasodilation Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• 230000029663 wound healing Effects 0.000 description 2
• 210000005253 yeast cell Anatomy 0.000 description 2
• SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
• JQFLYFRHDIHZFZ-RXMQYKEDSA-N (2s)-3,3-dimethylpyrrolidine-2-carboxylic acid Chemical compound CC1(C)CCN[C@@H]1C(O)=O JQFLYFRHDIHZFZ-RXMQYKEDSA-N 0.000 description 1
• CNPSFBUUYIVHAP-AKGZTFGVSA-N (2s)-3-methylpyrrolidine-2-carboxylic acid Chemical compound CC1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-AKGZTFGVSA-N 0.000 description 1
• FXGZFWDCXQRZKI-VKHMYHEASA-N (2s)-5-amino-2-nitramido-5-oxopentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)N[N+]([O-])=O FXGZFWDCXQRZKI-VKHMYHEASA-N 0.000 description 1
• CCAIIPMIAFGKSI-DMTCNVIQSA-N (2s,3r)-3-hydroxy-2-(methylazaniumyl)butanoate Chemical compound CN[C@@H]([C@@H](C)O)C(O)=O CCAIIPMIAFGKSI-DMTCNVIQSA-N 0.000 description 1
• LINMATFDVHBYOS-MBJXGIAVSA-N (2s,3r,4s,5r,6r)-2-[(5-bromo-1h-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C=C12 LINMATFDVHBYOS-MBJXGIAVSA-N 0.000 description 1
• CNPSFBUUYIVHAP-WHFBIAKZSA-N (2s,3s)-3-methylpyrrolidin-1-ium-2-carboxylate Chemical compound C[C@H]1CCN[C@@H]1C(O)=O CNPSFBUUYIVHAP-WHFBIAKZSA-N 0.000 description 1
• DTQNEFOKTXXQKV-HKUYNNGSSA-N (2s,3s)-n-[(2-methoxyphenyl)methyl]-2-phenylpiperidin-3-amine Chemical compound COC1=CC=CC=C1CN[C@@H]1[C@H](C=2C=CC=CC=2)NCCC1 DTQNEFOKTXXQKV-HKUYNNGSSA-N 0.000 description 1
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• 102000007445 2',5'-Oligoadenylate Synthetase Human genes 0.000 description 1
• 108010086241 2',5'-Oligoadenylate Synthetase Proteins 0.000 description 1
• OMGHIGVFLOPEHJ-UHFFFAOYSA-N 2,5-dihydro-1h-pyrrol-1-ium-2-carboxylate Chemical compound OC(=O)C1NCC=C1 OMGHIGVFLOPEHJ-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 1
• FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
• 101150096273 ADE2 gene Proteins 0.000 description 1
• 102000015936 AP-1 transcription factor Human genes 0.000 description 1
• 108050004195 AP-1 transcription factor Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 241000228431 Acremonium chrysogenum Species 0.000 description 1
• 241000251468 Actinopterygii Species 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 229930024421 Adenine Natural products 0.000 description 1
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
• 108010000239 Aequorin Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
• 108010025188 Alcohol oxidase Proteins 0.000 description 1
• 102100036826 Aldehyde oxidase Human genes 0.000 description 1
• 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 229920000856 Amylose Polymers 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 241001203868 Autographa californica Species 0.000 description 1
• 108700040077 Baculovirus p10 Proteins 0.000 description 1
• 102100029516 Basic salivary proline-rich protein 1 Human genes 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 235000018185 Betula X alpestris Nutrition 0.000 description 1
• 235000018212 Betula X uliginosa Nutrition 0.000 description 1
• 241000212384 Bifora Species 0.000 description 1
• 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
• 101001027327 Bos taurus Growth-regulated protein homolog alpha Proteins 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
• OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
• 206010006895 Cachexia Diseases 0.000 description 1
• 102000000584 Calmodulin Human genes 0.000 description 1
• 108010041952 Calmodulin Proteins 0.000 description 1
• 241000178270 Canarypox virus Species 0.000 description 1
• 241000222128 Candida maltosa Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000282461 Canis lupus Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 244000033714 Clidemia hirta Species 0.000 description 1
• 235000014277 Clidemia hirta Nutrition 0.000 description 1
• 101100007328 Cocos nucifera COS-1 gene Proteins 0.000 description 1
• 208000002881 Colic Diseases 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 238000011537 Coomassie blue staining Methods 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
• 241000702421 Dependoparvovirus Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 238000008157 ELISA kit Methods 0.000 description 1
• 206010049119 Emotional distress Diseases 0.000 description 1
• 108010067770 Endopeptidase K Proteins 0.000 description 1
• 208000037487 Endotoxemia Diseases 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 206010015226 Erythema nodosum Diseases 0.000 description 1
• 108010075944 Erythropoietin Receptors Proteins 0.000 description 1
• 102100036509 Erythropoietin receptor Human genes 0.000 description 1
• 241000206602 Eukaryota Species 0.000 description 1
• 208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 229920001917 Ficoll Polymers 0.000 description 1
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
• 206010016952 Food poisoning Diseases 0.000 description 1
• 208000019331 Foodborne disease Diseases 0.000 description 1
• 208000014540 Functional gastrointestinal disease Diseases 0.000 description 1
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
• 101150094690 GAL1 gene Proteins 0.000 description 1
• 102100028501 Galanin peptides Human genes 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 206010017964 Gastrointestinal infection Diseases 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 206010017999 Gastrointestinal pain Diseases 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 229930182566 Gentamicin Natural products 0.000 description 1
• CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
• LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 description 1
• VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 1
• 102000000340 Glucosyltransferases Human genes 0.000 description 1
• 108010055629 Glucosyltransferases Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
• 108010053070 Glutathione Disulfide Proteins 0.000 description 1
• 239000004471 Glycine Substances 0.000 description 1
• 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 1
• 108010092372 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Proteins 0.000 description 1
• 102000016355 Granulocyte-Macrophage Colony-Stimulating Factor Receptors Human genes 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 101150069554 HIS4 gene Proteins 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 208000037357 HIV infectious disease Diseases 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 102100027685 Hemoglobin subunit alpha Human genes 0.000 description 1
• 108091005902 Hemoglobin subunit alpha Proteins 0.000 description 1
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
• 101001125486 Homo sapiens Basic salivary proline-rich protein 1 Proteins 0.000 description 1
• 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
• 101100121078 Homo sapiens GAL gene Proteins 0.000 description 1
• 101000741885 Homo sapiens Protection of telomeres protein 1 Proteins 0.000 description 1
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 1
• YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
• PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010020772 Hypertension Diseases 0.000 description 1
• 235000003332 Ilex aquifolium Nutrition 0.000 description 1
• 241000209027 Ilex aquifolium Species 0.000 description 1
• 108700002232 Immediate-Early Genes Proteins 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 206010021518 Impaired gastric emptying Diseases 0.000 description 1
• 108010060231 Insect Proteins Proteins 0.000 description 1
• 101710203526 Integrase Proteins 0.000 description 1
• 229940122326 Interferon alpha agonist Drugs 0.000 description 1
• 229940105188 Interferon alpha antagonist Drugs 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 102000006992 Interferon-alpha Human genes 0.000 description 1
• 108010047761 Interferon-alpha Proteins 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 108010038452 Interleukin-3 Receptors Proteins 0.000 description 1
• 102000010790 Interleukin-3 Receptors Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
• 208000008081 Intestinal Fistula Diseases 0.000 description 1
• 206010022642 Intestinal dilatation Diseases 0.000 description 1
• 108090000862 Ion Channels Proteins 0.000 description 1
• 102000004310 Ion Channels Human genes 0.000 description 1
• 244000285963 Kluyveromyces fragilis Species 0.000 description 1
• 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
• 241001138401 Kluyveromyces lactis Species 0.000 description 1
• SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
• HXEACLLIILLPRG-YFKPBYRVSA-N L-pipecolic acid Chemical compound [O-]C(=O)[C@@H]1CCCC[NH2+]1 HXEACLLIILLPRG-YFKPBYRVSA-N 0.000 description 1
• DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 description 1
• KKJQZEWNZXRJFG-UHFFFAOYSA-N L-trans-4-Methyl-2-pyrrolidinecarboxylic acid Chemical compound CC1CNC(C(O)=O)C1 KKJQZEWNZXRJFG-UHFFFAOYSA-N 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
• 108010047357 Luminescent Proteins Proteins 0.000 description 1
• 102000006830 Luminescent Proteins Human genes 0.000 description 1
• 241001625930 Luria Species 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 102000043136 MAP kinase family Human genes 0.000 description 1
• 108091054455 MAP kinase family Proteins 0.000 description 1
• 101710141347 Major envelope glycoprotein Proteins 0.000 description 1
• 208000002720 Malnutrition Diseases 0.000 description 1
• 108700020482 Maltose-Binding protein Proteins 0.000 description 1
• 108010036176 Melitten Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 241001024304 Mino Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 206010048723 Multiple-drug resistance Diseases 0.000 description 1
• 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
• 101100243377 Mus musculus Pepd gene Proteins 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• 208000003926 Myelitis Diseases 0.000 description 1
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
• 102100030856 Myoglobin Human genes 0.000 description 1
• 108010062374 Myoglobin Proteins 0.000 description 1
• NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
• BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
• 102000005395 NF-kappa B p50 Subunit Human genes 0.000 description 1
• 108010006401 NF-kappa B p50 Subunit Proteins 0.000 description 1
• 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
• 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
• 241000221960 Neurospora Species 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 241000320412 Ogataea angusta Species 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 101150029183 PEP4 gene Proteins 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000282520 Papio Species 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 241000237988 Patellidae Species 0.000 description 1
• ZRWPUFFVAOMMNM-UHFFFAOYSA-N Patulin Chemical compound OC1OCC=C2OC(=O)C=C12 ZRWPUFFVAOMMNM-UHFFFAOYSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 101710176384 Peptide 1 Proteins 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 1
• 102000003992 Peroxidases Human genes 0.000 description 1
• 206010057249 Phagocytosis Diseases 0.000 description 1
• 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 1
• 108010053210 Phycocyanin Proteins 0.000 description 1
• 108010004729 Phycoerythrin Proteins 0.000 description 1
• 241000235648 Pichia Species 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 239000004952 Polyamide Substances 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 206010054048 Postoperative ileus Diseases 0.000 description 1
• 241000932075 Priacanthus hamrur Species 0.000 description 1
• 206010036790 Productive cough Diseases 0.000 description 1
• 102100038745 Protection of telomeres protein 1 Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• 241000382353 Pupa Species 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108020004518 RNA Probes Proteins 0.000 description 1
• 108020005067 RNA Splice Sites Proteins 0.000 description 1
• 238000002123 RNA extraction Methods 0.000 description 1
• 239000003391 RNA probe Substances 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 101100449534 Rattus norvegicus Cxcl1 gene Proteins 0.000 description 1
• 241000714474 Rous sarcoma virus Species 0.000 description 1
• 238000011579 SCID mouse model Methods 0.000 description 1
• 101150014136 SUC2 gene Proteins 0.000 description 1
• 108010077895 Sarcosine Proteins 0.000 description 1
• 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 206010040030 Sensory loss Diseases 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 108700025832 Serum Response Element Proteins 0.000 description 1
• 244000000231 Sesamum indicum Species 0.000 description 1
• 241000710960 Sindbis virus Species 0.000 description 1
• 108010068542 Somatotropin Receptors Proteins 0.000 description 1
• 238000002105 Southern blotting Methods 0.000 description 1
• 241000256251 Spodoptera frugiperda Species 0.000 description 1
• 241000191940 Staphylococcus Species 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 108010022394 Threonine synthase Proteins 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 108700009124 Transcription Initiation Site Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 241000255993 Trichoplusia ni Species 0.000 description 1
• 241000219793 Trifolium Species 0.000 description 1
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 206010046851 Uveitis Diseases 0.000 description 1
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 241000269370 Xenopus <genus> Species 0.000 description 1
• 229920002494 Zein Polymers 0.000 description 1
• PCBMGUSDYHYVBQ-SOOFDHNKSA-N [4-amino-2-[(3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-imidazol-5-yl]phosphonic acid Chemical compound P(=O)(O)(O)C=1N=C(NC1N)C1[C@H](O)[C@H](O)[C@H](O1)CO PCBMGUSDYHYVBQ-SOOFDHNKSA-N 0.000 description 1
• 210000001015 abdomen Anatomy 0.000 description 1
• 230000004308 accommodation Effects 0.000 description 1
• 108020002494 acetyltransferase Proteins 0.000 description 1
• 102000005421 acetyltransferase Human genes 0.000 description 1
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical class C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 230000002730 additional effect Effects 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 239000000853 adhesive Substances 0.000 description 1
• 230000001070 adhesive effect Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 238000012867 alanine scanning Methods 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 108010004469 allophycocyanin Proteins 0.000 description 1
• 229940037003 alum Drugs 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 230000000689 aminoacylating effect Effects 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 239000002870 angiogenesis inducing agent Substances 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 150000001450 anions Chemical class 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 208000022531 anorexia Diseases 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 102000025171 antigen binding proteins Human genes 0.000 description 1
• 108091000831 antigen binding proteins Proteins 0.000 description 1
• 210000000709 aorta Anatomy 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 210000001367 artery Anatomy 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 210000003567 ascitic fluid Anatomy 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 238000011888 autopsy Methods 0.000 description 1
• IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 1
• 239000013602 bacteriophage vector Substances 0.000 description 1
• 229910052788 barium Inorganic materials 0.000 description 1
• DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
• 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
• 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 230000000975 bioactive effect Effects 0.000 description 1
• 238000011953 bioanalysis Methods 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 230000008827 biological function Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000029918 bioluminescence Effects 0.000 description 1
• 238000005415 bioluminescence Methods 0.000 description 1
• 208000024330 bloating Diseases 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000000601 blood cell Anatomy 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 208000025698 brain inflammatory disease Diseases 0.000 description 1
• 238000009395 breeding Methods 0.000 description 1
• 230000001488 breeding effect Effects 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
• 230000003913 calcium metabolism Effects 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 102000028861 calmodulin binding Human genes 0.000 description 1
• 108091000084 calmodulin binding Proteins 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
• 229960004484 carbachol Drugs 0.000 description 1
• 150000001718 carbodiimides Chemical class 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 229910002091 carbon monoxide Inorganic materials 0.000 description 1
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
• 230000000747 cardiac effect Effects 0.000 description 1
• 238000005277 cation exchange chromatography Methods 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 210000004534 cecum Anatomy 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 210000004671 cell-free system Anatomy 0.000 description 1
• 108091092356 cellular DNA Proteins 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 239000012461 cellulose resin Substances 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 230000003196 chaotropic effect Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 239000013522 chelant Substances 0.000 description 1
• 229920001429 chelating resin Polymers 0.000 description 1
• 238000002144 chemical decomposition reaction Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 238000002038 chemiluminescence detection Methods 0.000 description 1
• 230000035572 chemosensitivity Effects 0.000 description 1
• 230000003399 chemotactic effect Effects 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 239000000064 cholinergic agonist Substances 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 208000019902 chronic diarrheal disease Diseases 0.000 description 1
• 208000016532 chronic granulomatous disease Diseases 0.000 description 1
• 238000002983 circular dichroism Methods 0.000 description 1
• DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 description 1
• 229960005132 cisapride Drugs 0.000 description 1
• DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 description 1
• 238000004140 cleaning Methods 0.000 description 1
• 238000012411 cloning technique Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 230000004600 colonic motility Effects 0.000 description 1
• 238000007398 colorimetric assay Methods 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 230000009989 contractile response Effects 0.000 description 1
• 239000002872 contrast media Substances 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 235000005687 corn oil Nutrition 0.000 description 1
• 239000002285 corn oil Substances 0.000 description 1
• 239000013601 cosmid vector Substances 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 230000001351 cycling effect Effects 0.000 description 1
• 230000000093 cytochemical effect Effects 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 206010061428 decreased appetite Diseases 0.000 description 1
• 230000013872 defecation Effects 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 229960002086 dextran Drugs 0.000 description 1
• 229960000633 dextran sulfate Drugs 0.000 description 1
• 238000002405 diagnostic procedure Methods 0.000 description 1
• 235000015872 dietary supplement Nutrition 0.000 description 1
• 238000001085 differential centrifugation Methods 0.000 description 1
• 238000002050 diffraction method Methods 0.000 description 1
• 230000001079 digestive effect Effects 0.000 description 1
• 102000004419 dihydrofolate reductase Human genes 0.000 description 1
• PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
• 230000010339 dilation Effects 0.000 description 1
• 238000007865 diluting Methods 0.000 description 1
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
• 230000009266 disease activity Effects 0.000 description 1
• 238000010494 dissociation reaction Methods 0.000 description 1
• 230000005593 dissociations Effects 0.000 description 1
• 230000009429 distress Effects 0.000 description 1
• 235000020188 drinking water Nutrition 0.000 description 1
• 239000003651 drinking water Substances 0.000 description 1
• 230000000857 drug effect Effects 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 201000006549 dyspepsia Diseases 0.000 description 1
• 150000002061 ecdysteroids Chemical class 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 238000002003 electron diffraction Methods 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 210000002308 embryonic cell Anatomy 0.000 description 1
• 210000001671 embryonic stem cell Anatomy 0.000 description 1
• 206010014599 encephalitis Diseases 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 210000003372 endocrine gland Anatomy 0.000 description 1
• 210000000105 enteric nervous system Anatomy 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 230000008378 epithelial damage Effects 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 150000002118 epoxides Chemical class 0.000 description 1
• 238000011067 equilibration Methods 0.000 description 1
• 229960003276 erythromycin Drugs 0.000 description 1
• 239000003797 essential amino acid Substances 0.000 description 1
• 235000020776 essential amino acid Nutrition 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• 229960005542 ethidium bromide Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000001400 expression cloning Methods 0.000 description 1
• 239000000284 extract Substances 0.000 description 1
• 206010016165 failure to thrive Diseases 0.000 description 1
• 210000003608 fece Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 235000019688 fish Nutrition 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 238000011010 flushing procedure Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 238000010230 functional analysis Methods 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 230000030135 gastric motility Effects 0.000 description 1
• 210000003736 gastrointestinal content Anatomy 0.000 description 1
• 238000012224 gene deletion Methods 0.000 description 1
• 230000004545 gene duplication Effects 0.000 description 1
• 229960002518 gentamicin Drugs 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960003180 glutathione Drugs 0.000 description 1
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 102000035122 glycosylated proteins Human genes 0.000 description 1
• 108091005608 glycosylated proteins Proteins 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 230000003394 haemopoietic effect Effects 0.000 description 1
• 229910052736 halogen Inorganic materials 0.000 description 1
• 150000002367 halogens Chemical class 0.000 description 1
• 230000035876 healing Effects 0.000 description 1
• 230000023560 heart growth Effects 0.000 description 1
• 108060003552 hemocyanin Proteins 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
• 208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 150000002411 histidines Chemical class 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 108091008039 hormone receptors Proteins 0.000 description 1
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
• 229910052739 hydrogen Inorganic materials 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• MWFRVMDVLYIXJF-BYPYZUCNSA-N hydroxyethylcysteine Chemical compound OC(=O)[C@@H](N)CSCCO MWFRVMDVLYIXJF-BYPYZUCNSA-N 0.000 description 1
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
• 206010020718 hyperplasia Diseases 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 208000008384 ileus Diseases 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000007233 immunological mechanism Effects 0.000 description 1
• 230000006054 immunological memory Effects 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000002584 immunomodulator Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 230000001771 impaired effect Effects 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 239000003112 inhibitor Substances 0.000 description 1
• 239000003999 initiator Substances 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 229960000367 inositol Drugs 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 230000008611 intercellular interaction Effects 0.000 description 1
• 230000008991 intestinal motility Effects 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000002601 intratumoral effect Effects 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
• 229960000310 isoleucine Drugs 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 210000001630 jejunum Anatomy 0.000 description 1
• 229960000318 kanamycin Drugs 0.000 description 1
• 229930027917 kanamycin Natural products 0.000 description 1
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
• 229930182823 kanamycin A Natural products 0.000 description 1
• 230000002147 killing effect Effects 0.000 description 1
• HXEACLLIILLPRG-RXMQYKEDSA-N l-pipecolic acid Natural products OC(=O)[C@H]1CCCCN1 HXEACLLIILLPRG-RXMQYKEDSA-N 0.000 description 1
• 210000003140 lateral ventricle Anatomy 0.000 description 1
• 239000010410 layer Substances 0.000 description 1
• 230000013016 learning Effects 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 150000002617 leukotrienes Chemical class 0.000 description 1
• 230000037356 lipid metabolism Effects 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 230000008752 local inflammatory process Effects 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 230000001071 malnutrition Effects 0.000 description 1
• 235000000824 malnutrition Nutrition 0.000 description 1
• 230000010311 mammalian development Effects 0.000 description 1
• 238000013507 mapping Methods 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 108010082117 matrigel Proteins 0.000 description 1
• VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 1
• 230000002503 metabolic effect Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
• 229960004503 metoclopramide Drugs 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 230000000116 mitigating effect Effects 0.000 description 1
• 230000008747 mitogenic response Effects 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 230000004660 morphological change Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 230000003551 muscarinic effect Effects 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 230000004118 muscle contraction Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000003957 neurotransmitter release Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 230000003472 neutralizing effect Effects 0.000 description 1
• 239000002547 new drug Substances 0.000 description 1
• 210000002445 nipple Anatomy 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 210000000929 nociceptor Anatomy 0.000 description 1
• 108091008700 nociceptors Proteins 0.000 description 1
• 230000036963 noncompetitive effect Effects 0.000 description 1
• 229960002748 norepinephrine Drugs 0.000 description 1
• SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 208000015380 nutritional deficiency disease Diseases 0.000 description 1
• 230000000050 nutritive effect Effects 0.000 description 1
• 229940054441 o-phthalaldehyde Drugs 0.000 description 1
• 230000000414 obstructive effect Effects 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 210000000287 oocyte Anatomy 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 230000003204 osmotic effect Effects 0.000 description 1
• 210000001672 ovary Anatomy 0.000 description 1
• YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 230000008058 pain sensation Effects 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000005298 paramagnetic effect Effects 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000003200 peritoneal cavity Anatomy 0.000 description 1
• 239000003330 peritoneal dialysis fluid Substances 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 108040007629 peroxidase activity proteins Proteins 0.000 description 1
• 235000020030 perry Nutrition 0.000 description 1
• 230000008782 phagocytosis Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• RXNXLAHQOVLMIE-UHFFFAOYSA-N phenyl 10-methylacridin-10-ium-9-carboxylate Chemical compound C12=CC=CC=C2[N+](C)=C2C=CC=CC2=C1C(=O)OC1=CC=CC=C1 RXNXLAHQOVLMIE-UHFFFAOYSA-N 0.000 description 1
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
• 101150078860 pho gene Proteins 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 150000004713 phosphodiesters Chemical class 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 150000008300 phosphoramidites Chemical class 0.000 description 1
• 108010085336 phosphoribosyl-AMP cyclohydrolase Proteins 0.000 description 1
• 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 239000000906 photoactive agent Substances 0.000 description 1
• 238000005222 photoaffinity labeling Methods 0.000 description 1
• ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 230000001817 pituitary effect Effects 0.000 description 1
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 229920002647 polyamide Polymers 0.000 description 1
• 229920002721 polycyanoacrylate Polymers 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 229920001223 polyethylene glycol Polymers 0.000 description 1
• 229920001282 polysaccharide Polymers 0.000 description 1
• 239000005017 polysaccharide Substances 0.000 description 1
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
• 235000020004 porter Nutrition 0.000 description 1
• 230000026341 positive regulation of angiogenesis Effects 0.000 description 1
• 238000002600 positron emission tomography Methods 0.000 description 1
• 229940124606 potential therapeutic agent Drugs 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 239000002325 prokinetic agent Substances 0.000 description 1
• 230000002062 proliferating effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000009696 proliferative response Effects 0.000 description 1
• 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 230000000644 propagated effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000019419 proteases Nutrition 0.000 description 1
• 230000001012 protector Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 238000000455 protein structure prediction Methods 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 229950010131 puromycin Drugs 0.000 description 1
• 210000001187 pylorus Anatomy 0.000 description 1
• 239000002510 pyrogen Substances 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 101150079601 recA gene Proteins 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 201000010727 rectal prolapse Diseases 0.000 description 1
• 239000001054 red pigment Substances 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000011514 reflex Effects 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 230000001850 reproductive effect Effects 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000004007 reversed phase HPLC Methods 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• 108700004121 sarkosyl Proteins 0.000 description 1
• 229940016590 sarkosyl Drugs 0.000 description 1
• 210000001991 scapula Anatomy 0.000 description 1
• 238000013391 scatchard analysis Methods 0.000 description 1
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• JRPHGDYSKGJTKZ-UHFFFAOYSA-K selenophosphate Chemical compound [O-]P([O-])([O-])=[Se] JRPHGDYSKGJTKZ-UHFFFAOYSA-K 0.000 description 1
• 230000001953 sensory effect Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 208000013223 septicemia Diseases 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 230000001568 sexual effect Effects 0.000 description 1
• 238000010008 shearing Methods 0.000 description 1
• 238000004904 shortening Methods 0.000 description 1
• 230000019491 signal transduction Effects 0.000 description 1
• 230000037432 silent mutation Effects 0.000 description 1
• 239000002356 single layer Substances 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 238000002791 soaking Methods 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 239000001488 sodium phosphate Substances 0.000 description 1
• 229910000162 sodium phosphate Inorganic materials 0.000 description 1
• 235000021055 solid food Nutrition 0.000 description 1
• 239000002904 solvent Substances 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 210000000278 spinal cord Anatomy 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 238000013222 sprague-dawley male rat Methods 0.000 description 1
• 238000012453 sprague-dawley rat model Methods 0.000 description 1
• 210000003802 sputum Anatomy 0.000 description 1
• 208000024794 sputum Diseases 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 235000000891 standard diet Nutrition 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 108010018381 streptavidin-binding peptide Proteins 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 210000003699 striated muscle Anatomy 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000004441 surface measurement Methods 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 208000011580 syndromic disease Diseases 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000008399 tap water Substances 0.000 description 1
• 235000020679 tap water Nutrition 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• NPDBDJFLKKQMCM-UHFFFAOYSA-N tert-butylglycine Chemical compound CC(C)(C)C(N)C(O)=O NPDBDJFLKKQMCM-UHFFFAOYSA-N 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
• 125000003831 tetrazolyl group Chemical group 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 230000017423 tissue regeneration Effects 0.000 description 1
• 238000011200 topical administration Methods 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 238000012549 training Methods 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000037317 transdermal delivery Effects 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 239000000439 tumor marker Substances 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 239000004474 valine Substances 0.000 description 1
• 229910052720 vanadium Inorganic materials 0.000 description 1
• 210000003501 vero cell Anatomy 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 230000009278 visceral effect Effects 0.000 description 1
• 238000012800 visualization Methods 0.000 description 1
• 210000004916 vomit Anatomy 0.000 description 1
• 229920003169 water-soluble polymer Polymers 0.000 description 1
• 230000004584 weight gain Effects 0.000 description 1
• 235000019786 weight gain Nutrition 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 238000002424 x-ray crystallography Methods 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1
• 239000005019 zein Substances 0.000 description 1
• 229940093612 zein Drugs 0.000 description 1